Vitamin B17 and Laetrile: The History, Claims, Controversy Behind a Disputed Cancer Theory

A controversial idea. A decades-long medical dispute. A historical record that still raises difficult questions about evidence, institutions, incentives, and dissent. Vitamin B17 and Laetrile examines the arguments that made Laetrile one of the most debated alternative cancer treatments of the twentieth century. Preserving the detailed historical case presented in the supplied source while adding clear modern context, this edition follows the controversy from early research disputes and the Sloan Kettering episode through deficiency-disease analogies, the "vitamin B17" theory, trophoblastic ideas of cancer, toxicity debates, practitioner reports, critiques of surgery, radiation and chemotherapy, and the statistical arguments used by Laetrile advocates. Inside, readers will explore: - why supporters compared cancer with historic deficiency diseases such as scurvy and pellagra; - how apricot kernels, amygdalin and Laetrile became linked to the term "vitamin B17"; - the scientific and institutional disputes that shaped the public controversy; - historical case reports, laboratory claims and practitioner statistics cited by advocates; - the source's criticism of conventional cancer treatment and cancer statistics; >This is not a treatment manual. Modern evidence does not establish Laetrile or amygdalin as an effective cancer therapy, and cyanide toxicity is a documented risk. The book is presented as a carefully edited historical examination of a controversial medical theory and the institutions, personalities, and arguments surrounding it. For readers interested in the history of medicine, alternative-health controversies, cancer policy, scientific dissent, and the evolution of evidence-based treatment, this edition offers a detailed look at one of the twentieth century's most persistent medical debates.